Endocrine Society Releases New Obesity Drug Treatment Guidelines

The Endocrine Society has published a guideline for the pharmacologic management of obesity in patients not achieving success with diet and exercise alone. These guidelines were developed to help providers identify patients who might benefit from pharmacotherapy for obesity and provide relevant evidence and background on available pharmacologic agents. The guidelines provide recommendations on medication use and dosage, including recommendations for patients with obesity-related comorbidities such as type 2 diabetes and cardiovascular disease. The guidelines also offer specific recommendations for transitioning patients off drugs that cause weight gain. You can follow this link to review the guidelines abstract or download the full text.